Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF

NCT02985268 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Functional Mitral Regurgitation
Heart Failure

Interventions

DEVICE: MitraClip
DRUG: Optimal Medical Therapy
DEVICE: CRT-D

Sponsor

Montreal Heart Institute